Cystic Fibrosis Therapeutics Market

Future Market Insights

Key Insight

The cystic fibrosis therapeutics market is projected to grow from USD 19.5 billion in 2025 to USD 181.9 billion by 2035, at a CAGR of 25.0%. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) will dominate with a 47.3% market share, while oral will lead the route of administration segment with a 61.5% share.

August 21, 2025

Anurag Sharma

299 Pages

Cite this Report

Cystic Fibrosis Therapeutics Market

https://www.futuremarketinsights.com/reports/cystic-fibrosis-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Allergen Plc
Bayer
Genentech Inc
Novartis

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Cystic Fibrosis Therapeutics Market

Key Players

Similar Industry Reports